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Channel Characteristics Expression Evidence from Animal Models Role in Humans
Nav1.3 TTX-sensitive, voltage-
gated sodium channel 
Embryonic DRG and TG neurons, spinal cord, and 
thalamus; upregulated in DRG and dorsal horn 
 neurons following nerve injury
Loss of function attenuates pain-related behavior Na+ channel blockers including local 
anesthetics, anticonvulsants, anti-
arrhythmic, and TCAs relieve pain 
associated with neuropathy, diabetes, 
osteoarthritis, and surgery. Mutations 
in the Nav1.7 gene (scn9a) cause 
erythromelalgia and paroxysmal extreme 
pain disorder; loss of function of Nav1.7 
results in pain insensitivity.
Nav1.7 TTX-sensitive, voltage-
gated sodium channel
Most adult DRG and TG neurons; upregulated in small 
DRG and TG neurons postinflammation
Loss of function reduces mechanical and thermal 
hypersensitivity; the Nav1.7/Nav1.8 blocker CDA54 
reduces neuropathic pain in nerve injury models
Nav1.8 TTX-resistant, voltage-
gated sodium channel
Small and medium DRG and TG neurons; upregulated 
in small DRG neurons after inflammation; down-
regulated in small DRG neurons in nerve injury models
Decrease in sensitivity to noxious thermal and 
mechanical stimuli in knockout mouse; Nav1.8 
blocker A-803467 reduces mechanical allodynia 
and thermal hyperalgesia
Nav1.9 TTX-resistant, voltage-
gated sodium channel
Small and medium DRG and TG neurons; silent noci-
ceptors; upregulated function in DRGs postinflammation
Loss of function reduces mechanical and thermal 
hypersensitivity associated with inflammatory pain
Possible involvement in chronic and 
inflammatory pain
Cav2.2 High-threshold, voltage-
gated calcium channel 
Small and medium DRG neurons, brainstem,  thalamus; 
increased expression in the dorsal horn of the spinal 
cord in neuropathic pain models; upregulated in DRGs 
following nerve injury and tissue inflammation
Loss of function leads to resistance to hyper-
algesia and allodynia following nerve injury 
Therapeutic target for pain associated 
with cancer, AIDS, and neuropathies; 
channel blockers are antinociceptive and 
undergoing clinical evaluation
Cav3.2-3.1 Low-threshold, voltage-
gated calcium channels 
Small and medium DRG neurons, spinal cord, 
 thalamus; increased current density observed in 
models of neuropathy
Knockdown of Cav3.2 leads to antinociceptive 
effects; knockout reduces pain responses and 
attenuates thermal hyperalgesia; channel blockers 
attenuate hyperalgesia (mibefradil) and mechanical 
allodynia (ethosuximide) 
Possible involvement in migraine pain 
and in analgesic effects of N2O and 
neuroactive steroids 
Cavα2δ1 Calcium channel auxil-
iary subunit
DRG neurons, dorsal horn of spinal cord, brainstem, 
thalamus; increased expression in DRGs and spinal 
cord in neuropathic pain models, nerve injury, and 
tissue inflammation 
Knockdown reduces pain-related behaviors; 
R217A α2δ1 knockin mice are unresponsive to 
the inhibitors gabapentin and pregabalin (used to 
treat pain)
Linked to fibromyalgia pain, posther-
petic neuralgia, and neuropathic pain 
 associated with cancer, diabetes, and 
HIV 
KCNQ 6 TM voltage-gated K+ 
channels of the Kv7 
family
Kv7.2, Kv7.3, and Kv7.5 are expressed in DRG 
neurons and at synapses of the pain transmission 
pathway
Retigabine reduces pain hyper sensitivity, 
 muscoskeletal pain, and behavioral hyper-
sensitivity to mechanical and cold stimulation 
Channel openers and second generation 
ligands are being developed for the 
treatment of migraine, muscle pain, 
and pain associated with osteoporosis, 
cancer, and neuropathy
Kv1–Kv4 6 TM voltage-gated, 
shaker-related K+ 
channels
Kv3.4 and Kv1.4 predominate in nociceptive DRG 
neurons; Kv1.1 and Kv1.2 predominate in large DRG 
neurons; Kv4.2 is expressed in dorsal horn neurons; 
expression of Kv3.4 and Kv4.3 in DRG is reduced after 
injury and Kv1.1-1.4 are reduced after axotomy
Downregulation of Kv3.4 causes  mechanical 
hypersensitivity; downregulation of Kv1.1 
 antagonizes antinociception
Possible role (Kv1.1) in antinociception 
induced by TCAs and H1-antihistamines; 
Kv4.2 may contribute to visceral pain 
states and to ERK-dependent forms of 
pain hypersensitivity
SK1–SK3 6 TM, small conduc-
tance Ca2+-activated K+ 
channels
SK1 and SK2 are expressed in putative nociceptors; 
SK2 localizes in the superficial laminae of the dorsal 
horn; SK3 is expressed in DRG neurons
The SK channel blocker apamin reduces the 
antinociceptive effects of cannabinoids 
May moderate afferent input and pain 
signals; possible roles in antinociception 
induced by TCAs, H1-antihistamines, 
and antiepileptic drugs
TREK1 4 TM K+ channel Highly expressed in small and medium DRG neurons Mice lacking TREK1 display enhanced  sensitivity 
to painful heat and increased thermal and 
 mechanical hyperalgesia 
Possible role in polymodal pain 
 perception and anesthetic-mediated 
antinociception
Kir3 2 TM family of K+ 
channels
Superficial layers of dorsal horn; Kir3.1 tyrosine 
phosphorylation occurs during acute and chronic 
inflammatory pain
Kir3.1 and Kir3.2 knockout mice display thermal 
hyperalgesia and reduced sensitivity to morphine
Possible mediators of both opioid- and 
ethanol-induced analgesia
TRPV1 ThermoTRP (≥43°C) 
nonselective cation 
channel
Small and medium DRG and TG neurons; 
 inflammation sensitizes TRPV1 function and increases 
expression; upregulated in inflammatory bowel 
disease
TRPV1 knockout mice have impaired thermal 
avoidance and reduced chemical, thermal, and 
mechanical hyperalgesia; capsaicin alleviates 
pain after topical application; antagonists alleviate 
mechanical and thermal hyperalgesia
Linked to gastroesophageal reflux 
 disease, vulvodynia, and osteoarthritis 
pain;  capsaicin transdermal patch is be-
ing used for the treatment of neuropathic 
pain associated with HIV and shingles
TRPV3 ThermoTRP (31°C 
–39°C) nonselective 
cation channel
Skin, spinal cord, brain, DRG, and TG neurons Loss of function leads to impaired thermal 
 avoidance
TRPV4 ThermoTRP (≥27°C) 
nonselective cation 
channel
Vibrissal Merkel cells, DRG and TG neurons, 
 mechanosensory terminals in the skin; inflammation 
engages TRPV4 in mechanical hyperalgesia
Knockout mice have impaired osmotic, thermal, 
and mechanical hyperalgesia
May be involved in pain in diabetes, 
alcoholism, aquadynia, and asthma
TRPM8 ThermoTRP (≤22°C 
–26°C) nonselective 
cation channel
Subset of small DRG neurons; upregulated expression 
in DRGs and spinal cord in nerve injury models
Knockout mice have reduced avoidance of cold 
temperature and insensitivity to the channel 
activator icilin; icilin elicits analgesia in multiple 
models of pain
Linked to painful bladder syndrome and 
idiopathic detrusor overactivity; possible 
role in innocuous and noxious cold 
transduction
TRPA1 ThermoTRP (≤17°C) 
nonselective cation 
channel
Small peptidergic DRG neurons; activity increased by 
bradykinin and inflammatory mediators
Knockout mice have impaired responses to 
irritants and bradykinin and reduced cold 
 hyperalgesia 
Possible role in the transduction of 
noxious cold and mechanical stimuli and 
in nociceptive responses to irritants
ASIC Acid-sensing Na+ 
 channels, subgroup of 
the degenerin family
ASIC1a, ASIC1b, ASIC2b, and ASIC3 expressed in 
small DRG neurons; ASIC1a, ASIC2a, ASIC2b, and 
ASIC3 are abundant in spinal cord; ASIC2 and ASIC3 
are present in Meissner’s corpuscles, palisades of 
 lanceolate fibers, Pilo-Ruffini nerve endings, and 
Merkel cells; spinal nerve injury induces differential 
regulation of ASIC subunit expression
Knockdown of ASIC1a attenuates thermal and 
mechanical hypersensitivity; ASIC3 knockout mice 
have reduced visceral mechanosensitivity and no 
gastric acid hyper-responsiveness; channel-block-
ing compounds psamotoxin (ASIC1a), amiloride, 
and A317567 (ASIC1-3) have analgesic effects
Possible role in acid-induced 
 nociception, visceral discomfort, and 
chronic inflammatory arthritis 
HCN Hyperpolarization- 
activated, cyclic 
 nucleotide-gated 
channels
DRG neurons, Meissner’s corpuscules, and Merkel 
cells; HCN channels accumulate at injury sites 
ZD7288 reverses tactile allodynia induced by 
spinal nerve ligation and mild thermal injury
Possible role in mechanical allodynia and 
ectopic discharges in neuropathic painSee online version for glossary, acknowledgments, and references.366 Cell 134, July 25, 2008 ©2008 Elsevier Inc. DOI 10.1016/j.cell.2008.07.006
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Glossary
AIDS: acquired immunodeficiency syndrome
Allodynia: a sensation of pain to a stimulus that is not normally painful
Antinociceptive: reduces sensitivity to a painful stimuli
Aquadynia: pain induced by contact with water
Detrusor overactivity: involuntary contractions of the detrusor muscle of the urinary system during filling of the bladder
DRG: dorsal root ganglion
ERK: extracellular signal-regulated kinase
Erythromelalgia: a disorder marked by paroxysmal, bilateral vasodilatation, with burning pain, and increased skin temperature
Fibromyalgia: a disorder characterized by chronic widespread pain; patients display enhanced sensitivity to multiple stimuli
HIV: human immunodeficiency virus
Hyperalgesia: an increased sensitivity to pain
Meissner’s corpuscles: a nerve ending in the skin that mediates sensation of light touch
Merkel cells: sensory cells found in the epidermis and associated with sense of touch
Palisades of lanceolate fibers: specialized nerve endings in the skin that surround hair shafts
Pilo-Ruffini nerve endings: terminals of slowly adapting mechanoreceptors
Postherpetic neuralgia: a painful complication of shingles
TCA: tricyclic antidepressant
TG: trigeminal ganglion
TM: transmembrane
TRP: transient receptor potential
TTX: tetrodotoxin 
Vulvodynia: a disorder characterized by chronic pain of the vulva
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